Your browser is no longer supported. Please, upgrade your browser.
Settings
CELG Celgene Corporation daily Stock Chart
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E17.13 EPS (ttm)5.28 Insider Own0.10% Shs Outstand716.10M Perf Week-0.92%
Market Cap64.71B Forward P/E8.54 EPS next Y10.58 Insider Trans-10.51% Shs Float700.68M Perf Month5.89%
Income4.07B PEG0.89 EPS next Q2.22 Inst Own76.10% Short Float2.20% Perf Quarter15.31%
Sales14.12B P/S4.58 EPS this Y109.10% Inst Trans-5.62% Short Ratio2.38 Perf Half Y-5.13%
Book/sh4.79 P/B18.87 EPS next Y20.88% ROA8.60% Target Price111.98 Perf Year-29.17%
Cash/sh4.76 P/C18.98 EPS next 5Y19.24% ROE44.10% 52W Range74.13 - 147.17 Perf YTD-13.41%
Dividend- P/FCF19.23 EPS past 5Y25.80% ROI20.00% 52W High-38.59% Beta1.32
Dividend %- Quick Ratio1.40 Sales past 5Y18.70% Gross Margin96.50% 52W Low21.91% ATR1.78
Employees7467 Current Ratio1.50 Sales Q/Q-38.80% Oper. Margin28.20% RSI (14)57.93 Volatility2.03% 2.08%
OptionableYes Debt/Eq6.20 EPS Q/Q-42.90% Profit Margin19.80% Rel Volume0.64 Prev Close90.15
ShortableYes LT Debt/Eq5.76 EarningsJul 26 BMO Payout0.00% Avg Volume6.47M Price90.37
Recom2.20 SMA201.09% SMA507.41% SMA200-1.82% Volume4,120,360 Change0.24%
Jun-18-18Upgrade Standpoint Research Hold → Buy
May-29-18Reiterated SunTrust Hold $106 → $96
May-23-18Upgrade Bernstein Mkt Perform → Outperform
May-23-18Downgrade Argus Buy → Hold
May-07-18Downgrade RBC Capital Mkts Top Pick → Outperform
Apr-13-18Resumed Morgan Stanley Equal-Weight $93
Mar-26-18Reiterated Goldman Sell $97 → $85
Mar-21-18Resumed JP Morgan Overweight $110
Feb-28-18Reiterated Stifel Buy $130 → $128
Feb-28-18Downgrade SunTrust Buy → Hold
Feb-13-18Upgrade Barclays Equal Weight → Overweight $105
Jan-26-18Reiterated SunTrust Buy $127 → $139
Jan-05-18Downgrade BofA/Merrill Buy → Neutral
Dec-27-17Downgrade Bernstein Outperform → Mkt Perform
Dec-22-17Reiterated Stifel Buy $149 → $130
Dec-08-17Upgrade Atlantic Equities Neutral → Overweight
Oct-27-17Upgrade Morgan Stanley Underweight → Equal-Weight
Oct-27-17Reiterated SunTrust Buy $156 → $127
Oct-27-17Reiterated Barclays Equal Weight $135 → $105
Oct-27-17Downgrade JMP Securities Mkt Outperform → Mkt Perform
Aug-16-18 08:48AM  10 Roughed-Up Stocks to Buy for a Recovery Rally Kiplinger
07:00AM  Market Morning: Gene Therapy Deregulation, Amazon to the Movies, SEC On Musks Tail Market Exclusive
06:31AM  3 Great Stocks for Your IRA Motley Fool
Aug-14-18 09:36AM  13 of the Cheapest Healthcare Stocks Motley Fool
Aug-13-18 09:00PM  3 Top Biotech Stocks to Buy Right Now Motley Fool
02:06PM  Turkey Drives Up Worry: Global Week Ahead Zacks
Aug-11-18 02:10PM  3 Top Value Stocks to Buy Right Now Motley Fool
Aug-10-18 10:59AM  Corcept (CORT) Earnings and Revenues Miss Estimates in Q2 Zacks
09:00AM  Why Celgene Corporation Bounced Back in July Motley Fool
Aug-09-18 10:25PM  Carl Icahn Fires Shots at Express Scripts Motley Fool
04:05PM  5 Top Stock Trades for Friday Buy Yelp, Roku After Earnings Surge? InvestorPlace
02:50PM  7 "Zombie Stocks" That Are Coming Back to Life Kiplinger
10:00AM  Is Crispr Therapeutics Stock Grossly Overvalued? Motley Fool
09:28AM  Your first trade for Thursday, August 9 CNBC
09:24AM  Inspired By Tesla: RBC Speculates On Go-Private Scenario For Celgene Benzinga
Aug-08-18 06:10PM  Final Trade: CELG, BABA & more CNBC Videos
04:17PM  Could Biotech Giant Celgene Join Tesla In The Private Markets? Investor's Business Daily
01:49PM  Musk's Ambitions Rekindle Celgene Privatization Musings at RBC Bloomberg
01:46PM  Bulls bet on one underperforming biotech name. Plus, an e... CNBC Videos
11:21AM  Protagonist Stock Jumps 58% After Re-Review of Test Results InvestorPlace
08:18AM  Prothena (PRTA) Q2 Earnings Lag Estimates, Pipeline in Focus Zacks
Aug-07-18 08:05AM  The Zacks Analyst Blog Highlights: Caterpillar, BHP Billiton and Celgene Zacks
Aug-06-18 04:15PM  Can These Biotech Companies Catch Novartis, Gilead In CAR-T? Investor's Business Daily
02:47PM  bluebird bio Prepares Its "Transition to a Commercial Company" Motley Fool
11:09AM  Quiet in August: Global Week Ahead Zacks
Aug-04-18 01:11PM  Here's Why Acceleron Pharma Inc. Lost 10.2% in July Motley Fool
Aug-03-18 05:30PM  Prothena (PRTA) Q2 Earnings: Is a Disappointment in Store? Zacks
12:54PM  bluebird (BLUE) Q2 Loss Wider Than Expected, Revenues Miss Zacks
11:55AM  Agios (AGIO) Q2 Loss Narrows, Revenues Surpass Estimates Zacks
11:32AM  Health-care pharma stocks are on fire, here's how to trad... CNBC Videos
08:49AM  Regeneron Pharmaceuticals (REGN) Jumps: Stock Rises 7% Zacks
07:55AM  Zacks.com featured highlights include: Celgene, Progressive, T. Rowe Price, AMC and Celanese Zacks
Aug-02-18 12:55PM  Adding Biotech ETFs to Your Portfolio Investopedia
09:18AM  Top 5 ROE Picks as Q2 Earnings Shine Despite Trade War Woes Zacks
08:06AM  The Zacks Analyst Blog Highlights: Celgene, Exxon Mobil, Berkshire Hathaway, Phillips 66 and VMware Zacks
Aug-01-18 06:05PM  Final Trade: PYPL, SQ & more CNBC Videos
02:14PM  Buy Disney ahead of earnings? Has Celgene bottomed, and m... CNBC Videos
12:13PM  Top Stock Reports for Celgene, Exxon Mobil & Berkshire Hathaway Zacks
09:34AM  Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit Zacks
12:00AM  [$$] Trump is losing the war on drug prices Financial Times
Jul-30-18 12:09PM  Could Gilead Merge With Pfizer Or Vertex To Solve Its CEO Problem? Investor's Business Daily
11:25AM  What's in the Cards for Agios (AGIO) Stock in Q2 Earnings? Zacks
11:00AM  3 Biotech Stocks to Watch at The End of July ACCESSWIRE
Jul-29-18 09:31AM  Why Celgene Is Looking Less Risky and More Attractive Motley Fool
09:31AM  Can Celgenes Most Important Drugs Keep Growing? Motley Fool
Jul-28-18 05:14PM  Edited Transcript of CELG earnings conference call or presentation 26-Jul-18 1:00pm GMT Thomson Reuters StreetEvents
04:20PM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
10:30AM  Drugmakers sure are eager to talk about drug prices lately MarketWatch
Jul-27-18 12:48PM  Celgene (CELG) Q2 2018 Earnings Conference Call Transcript Motley Fool
07:35AM  Initiating Free Research Reports on Celgene and Three Other Biotech Equities ACCESSWIRE
Jul-26-18 04:37PM  Celgene (CELG) Beats Q2 Earnings & Sales Estimates, Ups View Zacks
01:23PM  MARKETS: Facebook aside, earnings are rolling in positive and boosting stocks Yahoo Finance Video
01:08PM  Final trades: MasterCard, Celgene, Fifth Third & Industri... CNBC Videos
11:43AM  Biotech Earnings: Celgene, Gilead Stocks Head in Opposite Directions Barrons.com
11:31AM  Celgene profit tops expectations, will limit future price hikes Reuters
09:17AM  Celgene (CELG) Beats on Q2 Earnings, Ups View Zacks
08:01AM  Celgene: 2Q Earnings Snapshot Associated Press
07:50AM  Celgene shares lift on Q2 profit, revenue beats and upbeat 2018 guidance MarketWatch
07:39AM  Celgene quarterly profit drops 5 pct Reuters
07:30AM  Celgene Reports Second Quarter 2018 Operating and Financial Results Business Wire
Jul-25-18 03:36PM  Celgene Q2 Earnings Preview Benzinga
10:27AM  Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More Zacks
07:00AM  Did This Top Biotech Stock Just Go on Sale? Motley Fool
Jul-24-18 11:00AM  Biotech Boosted by Biogen Earnings, Celgene Trial Data Barrons.com
08:53AM  Benzinga's Daily Biotech Pulse: Celgene's Lymphoma Trial Meets Endpoint, Merit Medical's Strong Q2, Bluebird Bio Offering Benzinga
07:32AM  Celgene shares lift on positive results for cancer drug trial MarketWatch
05:00AM  Celgene Climbs on Lymphoma Drug Study Results Investopedia
Jul-23-18 05:47PM  Whats Next for Pfizer Stock After Being Called Out by President Trump InvestorPlace
04:53PM  Celgene (CELG) Q2 Earnings: Disappointment in Store? Zacks
04:30PM  Celgene Announces Phase III AUGMENT Study of REVLIMID® in Combination with Rituximab (R2) for the Treatment of Patients with Relapsed/Refractory Indolent Lymphoma Met Primary Endpoint Business Wire
08:01AM  Better Buy: Gilead Sciences, Inc. vs. Celgene Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: Celgene and BeiGene ACCESSWIRE
Jul-22-18 11:55PM  Top 3 Healthcare Stocks for 2018 Investopedia
07:30PM  The Global Cannabis Market Is Set To Explode Oilprice.com
Jul-19-18 08:46AM  The 3 Worst Healthcare Stocks of 2018 (So Far) Motley Fool
07:00AM  Are CEOs Really Worth What Theyre Paid? InvestorPlace
Jul-18-18 09:12PM  New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock InvestorPlace
10:32AM  Big money rolls in as GOP challenger pressures NJ Democrat Menendez for traditionally safe Senate seat CNBC
06:59AM  Biotech's Coming Back to Life: Cramer's 'Off the Charts' TheStreet.com
Jul-17-18 07:01PM  Cramer's charts suggest big-name biotech stocks Gilead an... CNBC Videos
07:00PM  Charts: Gilead and Celgene have more room to run CNBC Videos
06:45PM  Cramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run CNBC
Jul-15-18 06:32AM  3 Best Big Pharma Stocks to Buy for the 2nd Half of 2018 Motley Fool
Jul-13-18 07:31AM  Why Celgene Corporation Lost 23.9% of Its Value Halfway Through 2018 Motley Fool
06:00AM  Biotech Celgene's Stock Seen Rebounding 14% Investopedia
Jul-12-18 05:23PM  Ex-Drug CEO Running for Senate Seat Attacked by Old Industry Foe Bloomberg
02:59PM  Nohla adds $11 million in funding and three new investors American City Business Journals
10:11AM  3 Real Risks That Could Make You Reconsider Buying Celgene Stock InvestorPlace
12:00AM  Many Drugmakers Ignore Trumpand Raise Prices Anyway Bloomberg
Jul-11-18 07:05PM  Top 5 Biotech Stocks for 2018 Investopedia
04:49PM  Celgene Reports Positive Data on Tecentriq, Abraxane Study Zacks
03:11PM  Russian Drugmaker Granted License to Produce Celgene Copycat Fortune
09:41AM  Biotech Stock Roundup: BIIB's Gain on Alzheimer's Data, Regulatory Updates & More Zacks
08:00AM  Today's Research Reports on Trending Tickers: Galapagos and Celgene ACCESSWIRE
Jul-10-18 04:06PM  Dow, S&P 500 Gain For Fourth Day; Nasdaq Ends Flat TheStreet.com
02:50PM  Celgene, Acceleron Report Positive Data on Thalassemia Drug Zacks
11:52AM  Upbeat Celgene Data Not Enough to Lift Biotech Sector Barrons.com
11:32AM  Stocks - PepsiCo, Celgene Gain in Pre-Market, EBay Falls, OncoCyte Soars Investing.com
09:24AM  Stocks to Watch: Microsoft, Pepsi, Amazon, Walmart, Disney, eBay, Smucker, Electronic Arts, Celgene The Wall Street Journal
08:11AM  Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna Coverage Benzinga
Celgene Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases worldwide. It offers REVLIMID, an oral immunomodulatory drug for multiple myeloma (MM), myelodysplastic syndromes (MDS), and mantle cell lymphoma; POMALYST/IMNOVID to treat multiple myeloma; OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis and psoriasis; and ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers. The company's products also include IDHIFA, a small molecule inhibitor of the isocitrate dehydrogenase 2 to treat acute myeloid leukemia (AML); VIDAZA, a pyrimidine nucleoside analog for intermediate-2 and high-risk MDS, chronic myelomonocytic leukemia, and AML; and THALOMID to treat patients with MM and erythema nodosum leprosum. Its clinical stage products comprise OTEZLA for use in treating various immune-inflammatory diseases; luspatercept for the treatment of patients with beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; LSD1 inhibitor to treat non-hodgkin lymphoma and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; CC-92480 to treat multiple myeloma; and durvalumab, an anti-PD-L1 antibody for multiple hematological cancers. The company has agreement with BeiGene, Ltd; Acceleron Pharma, Inc.; Agios Pharmaceuticals, Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; Nurix Inc.; Vividion Therapeutics, Inc.; Jounce Therapeutics, Inc.; Prothena Corporation plc; Zymeworks Inc.; and Evotec AG, as well as strategic collaboration with Skyhawk Therapeutics, Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARIO ERNESTDirectorAug 09Sale92.3212,0001,107,88844,413Aug 13 04:05 PM
BARKER RICHARD WDirectorJun 17Option Exercise0.001,000012,846Jun 18 04:00 PM
CASEY MICHAEL DDirectorJun 17Option Exercise0.0033400Jun 18 04:00 PM
Friedman Michael ADirectorJun 17Option Exercise0.0033400Jun 18 04:00 PM
LOUGHLIN JAMES JDirectorJun 17Option Exercise0.00334037,436Jun 18 04:00 PM
MARIO ERNESTDirectorJun 17Option Exercise0.00334056,413Jun 18 04:00 PM
Haller Julia ADirectorJun 15Option Exercise0.0037501,250Jun 15 04:57 PM
MARIO ERNESTDirectorJun 15Option Exercise0.00375056,079Jun 15 04:23 PM
BONNEY MICHAEL WDirectorJun 15Option Exercise0.0037501,050Jun 15 04:17 PM
CASEY MICHAEL DDirectorJun 15Option Exercise0.0037500Jun 15 04:16 PM
LOUGHLIN JAMES JDirectorJun 15Option Exercise0.002,441037,102Jun 15 04:13 PM
Friedman Michael ADirectorJun 15Option Exercise0.002,41300Jun 15 04:12 PM
Haller Julia ADirectorJun 14Option Exercise0.003000875Jun 15 04:57 PM
MARIO ERNESTDirectorJun 14Option Exercise0.00300055,704Jun 15 04:23 PM
BONNEY MICHAEL WDirectorJun 14Option Exercise0.003000675Jun 15 04:17 PM
CASEY MICHAEL DDirectorJun 14Option Exercise0.0030000Jun 15 04:16 PM
LOUGHLIN JAMES JDirectorJun 14Option Exercise0.00300034,661Jun 15 04:13 PM
Friedman Michael ADirectorJun 14Option Exercise0.0030000Jun 15 04:12 PM
COX CARRIE SMITHDirectorJun 12Option Exercise0.006,200030,080Jun 14 04:35 PM
CASEY MICHAEL DDirectorJun 07Option Exercise30.0127,750832,77827,750Jun 11 04:06 PM
CASEY MICHAEL DDirectorJun 07Sale78.7713,0001,024,0100Jun 11 04:06 PM
LOUGHLIN JAMES JDirectorJun 04Option Exercise30.0127,750832,77852,111Jun 05 04:15 PM
LOUGHLIN JAMES JDirectorJun 04Sale78.9617,7501,401,54034,361Jun 05 04:15 PM
Masoudi GeraldSEE REMARKSJun 01Option Exercise0.0015,000020,235Jun 05 04:09 PM
Alles Mark JCEO, CHAIRMAN OF BOARDMay 09Buy82.601,20899,784187,316May 17 04:08 PM
Curran TerrieMay 04Option Exercise0.002,50007,507May 08 04:56 PM
VESSEY RUPERTMay 04Option Exercise0.0078103,731May 08 04:36 PM
KELLOGG PETER NMay 04Option Exercise0.003,500050,831May 08 04:34 PM
Alles Mark JCEO, CHAIRMAN OF BOARDMay 04Option Exercise0.003,5000187,627May 08 04:30 PM
LOUGHLIN JAMES JDirectorMar 12Option Exercise27.189,250251,41533,611Mar 13 04:22 PM
LOUGHLIN JAMES JDirectorMar 12Sale92.019,250851,09324,361Mar 13 04:22 PM
MARIO ERNESTDirectorFeb 23Sale94.4913,3701,263,29855,404Feb 26 04:11 PM
KAPLAN GILLADirectorFeb 20Sale94.839,250877,17876,301Feb 20 05:02 PM
Smith Scott AndrewSee RemarksFeb 17Option Exercise0.007,283051,748Feb 20 05:03 PM
KELLOGG PETER NSee RemarksFeb 17Option Exercise0.007,283049,660Feb 20 05:03 PM
Alles Mark JSee RemarksFeb 17Option Exercise0.007,2830186,187Feb 20 05:00 PM
KAPLAN GILLADirectorFeb 15Option Exercise27.189,250251,41594,801Feb 20 05:02 PM
KAPLAN GILLADirectorFeb 15Sale95.999,250887,89885,551Feb 20 05:02 PM
Alles Mark JSee RemarksFeb 08Buy91.903,260299,594178,904Feb 08 04:47 PM
VESSEY RUPERTSee remarksFeb 02Option Exercise0.005,62305,623Feb 05 04:39 PM
Smith Scott AndrewSee RemarksDec 19Option Exercise0.003,410046,233Dec 20 04:05 PM
KELLOGG PETER NSee RemarksDec 19Option Exercise0.003,410044,145Dec 20 04:04 PM
Curran TerrieSee remarksDec 19Option Exercise0.001,76505,690Dec 20 04:03 PM
Alles Mark JSee RemarksDec 19Option Exercise0.004,5500177,738Dec 20 04:02 PM
KAPLAN GILLADirectorDec 05Option Exercise24.979,250230,92685,551Dec 06 04:45 PM
MARIO ERNESTDirectorOct 30Option Exercise31.8013,600432,41271,024Nov 01 04:11 PM
KELLOGG PETER NSee RemarksOct 27Option Exercise0.002,100041,823Oct 31 04:10 PM
HUGIN ROBERT Jsee remarksOct 26Option Exercise31.8162,0201,972,5501,060,106Oct 26 04:44 PM
Curran TerrieSee remarksSep 25Sale143.891,727248,4983,925Sep 26 04:29 PM
KAPLAN GILLADirectorSep 12Option Exercise33.889,250313,39085,551Sep 14 04:35 PM
KAPLAN GILLADirectorSep 12Sale141.569,2501,309,43076,301Sep 14 04:35 PM
CASEY MICHAEL DDirectorSep 05Sale139.039,2501,286,0280Sep 06 06:53 PM